TickerFactsScreenerDevelopers

Enliven Therapeutics, Inc. (ELVN) — Shares Outstanding

Annual figures by fiscal year, from SEC filings.

2019: 702.5K2020: 17.55M2021: 26.29M2022: 3.57M2023: 41.29M2024: 48.94M2025: 59.44M59.44M
2019Shares Outstanding (shares)2025
Fiscal YearShares OutstandingChange YoY
202559.44M+21.5%
202448.94M+18.5%
202341.29M+1056.6%
20223.57M-86.4%
202126.29M+49.8%
202017.55M+2397.9%
2019702.5K—